NCT01444586

Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)

Prospective Multicentre Non-interventional Study on Compliance and Patient/Doctor Behavior of VTE Prevention in Major Orthopedic Surgery

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,293 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a local, prospective, multicenter, non-interventional, observational study. Primary objective is to describe how in "real life" thromboprophylaxis is carried out after the discharge from a hospital in the patients who undergo elective knee and hip replacement and who receive Xarelto during hospitalization.

Conditions

• Arthroplasty, Replacement, Hip
• Arthroplasty, Replacement, Knee

Interventions

Type	Name	Description
DRUG	Rivaroxaban (Xarelto, BAY59-7939)	The patients will be treated according to the routine practice. All the patients meeting the criteria of inclusion and exclusion to whom administration of Xarelto is indicated are fit for participation in this non-interventional study.

Timeline

• Start date: 2011-10-01
• Primary completion: 2013-08-01
• Completion: 2014-07-01
• First posted: 2011-10-03
• Last updated: 2017-01-23

Locations

1 site across 1 country: Russia